Kjellson Nina S

DirectorTyra Biosciences, Inc. (TYRA) · full profile →Form 4 · filed Nov 1, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.3M
Net Open-Market Flow
-$2.3M
Transactions
8
8 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 1, 2024Sell(S)604$17.16$10K3.8M
Nov 1, 2024Sell(S)73$17.16$1K459K
Nov 1, 2024Sell(S)24K$16.54$396K3.8M
Nov 1, 2024Sell(S)3K$16.54$48K459K
Oct 31, 2024Sell(S)11K$16.46$177K461K
Oct 31, 2024Sell(S)89K$16.46$1.5M3.8M
Oct 30, 2024Sell(S)10K$16.17$160K3.9M
Oct 30, 2024Sell(S)1K$16.17$19K472K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-120198) within minutes of acceptance. Every field above traces to the original document. Verify it directly: